Substance P in the medial amygdala: Emotional stress-sensitive release and modulation of anxiety-related behavior in rats
暂无分享,去创建一个
Alois Saria | Nicolas Singewald | N. Singewald | A. Saria | K. Ebner | Karl Ebner | N. Rupniak | Nadia M Rupniak
[1] N. Ogawa,et al. Effect of immobilization stress on neuropeptides and their receptors in rat central nervous system , 1986, Regulatory Peptides.
[2] M. Adler,et al. Substance P release in the rat periaqueductal gray and preoptic anterior hypothalamus after noxious cold stimulation: effect of selective mu and kappa opioid agonists. , 1997, The Journal of pharmacology and experimental therapeutics.
[3] A. Fleming,et al. The long lasting effects of electrical simulation of the medial preoptic area and medial amygdala on maternal behavior in female rats , 1999, Behavioural Brain Research.
[4] M. Brandão,et al. Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test , 1996, Physiology & Behavior.
[5] J. Herman,et al. Differential forebrain c-fos mRNA induction by ether inhalation and novelty: evidence for distinctive stress pathways , 1999, Brain Research.
[6] L. Terenius,et al. Elevation of substance P-like peptides in the CSF of psychiatric patients. , 1984, Biological psychiatry.
[7] P. Kalivas,et al. Substance P modulation of dopamine in the nucleus accumbens , 1984, Neuroscience Letters.
[8] L. Swanson,et al. Organization of projections from the basomedial nucleus of the amygdala: A PHAL study in the rat , 1996, The Journal of comparative neurology.
[9] N. Canteras,et al. The role of lateral septal NK1 receptors in mediating anxiogenic effects induced by intracerebroventricular injection of substance P , 2002, Behavioural Brain Research.
[10] J. Lachowicz,et al. The Gerbil Elevated Plus-maze II: Anxiolytic-like Effects of Selective Neurokinin NK1 Receptor Antagonists , 2002, Neuropsychopharmacology.
[11] P. J. Larsen,et al. Endogenous substance P inhibits the expression of corticotropin-releasing hormone during a chronic inflammatory stress. , 1995, Life sciences.
[12] A. Bilkei-Gorzo,et al. Diminished Anxiety- and Depression-Related Behaviors in Mice with Selective Deletion of the Tac1 Gene , 2002, The Journal of Neuroscience.
[13] D. Smith,et al. The substance P antagonist L-760,735 inhibits stress-induced NK1 receptor internalisation in the basolateral amygdala , 1999, Brain Research.
[14] Guy Sandner,et al. Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze , 1993, Behavioural Brain Research.
[15] T. Kaneko,et al. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat , 1994, The Journal of comparative neurology.
[16] B J Allen,et al. Noxious Cutaneous Thermal Stimuli Induce a Graded Release of Endogenous Substance P in the Spinal Cord: Imaging Peptide ActionIn Vivo , 1997, The Journal of Neuroscience.
[17] T. Unger,et al. Central tachykinins: mediators of defence reaction and stress reactions. , 1995, Canadian journal of physiology and pharmacology.
[18] P. Mantyh. Neurobiology of substance P and the NK1 receptor. , 2002, The Journal of clinical psychiatry.
[19] C. Dayas,et al. Neuroendocrine responses to an emotional stressor: evidence for involvement of the medial but not the central amygdala , 1999, The European journal of neuroscience.
[20] G. Chrousos,et al. Neuroendocrinology of stress. , 2001, Endocrinology and metabolism clinics of North America.
[21] R. Adamec,et al. Effects of baseline anxiety on response to kindling of the right medial amygdala , 2000, Physiology & Behavior.
[22] S. Hunt,et al. Substance P receptors: Localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand , 1984, Brain Research.
[23] B. McEwen,et al. Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior , 2003, Nature Neuroscience.
[24] Charles B. Nemeroff,et al. Stress and psychiatric disorders , 1994 .
[25] R. Roth,et al. Mild footshock stress dissociates substance P from substance K and dynorphin from Met- and Leu-enkephalin , 1986, Brain Research.
[26] G. Bernatzky,et al. Characterization of substance P-like immunoreactivity in submammalian species by high performance liquid chromatography , 1985, Peptides.
[27] P. Eneroth,et al. Short-term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri-aqueductal grey and limbic regions of rat brain. , 1992, Acta physiologica Scandinavica.
[28] R. Whelpton,et al. Substance P modulation of striatal dopamine outflow is determined by M1 and M2 muscarinic receptors in male Wistar rats , 2000, Neuroscience Letters.
[29] George B Stefano,et al. The role of stress in neurodegenerative diseases and mental disorders. , 2002, Neuro endocrinology letters.
[30] S. File,et al. Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.
[31] M Tanaka,et al. Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. , 2000, European journal of pharmacology.
[32] D. Blanchard,et al. Innate and conditioned reactions to threat in rats with amygdaloid lesions. , 1972, Journal of comparative and physiological psychology.
[33] D. Morilak,et al. Modulatory effects of norepinephrine, acting on alpha1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress , 2002, Neuropharmacology.
[34] J. Nurnberger,et al. CSF substance P immunoreactivity in affective disorders , 1985, Biological Psychiatry.
[35] U. Ungerstedt,et al. Microdialysis combined with a sensitive radioimmunoassay. A technique for studying in vivo release of neuropeptides. , 1987, Journal of pharmacological methods.
[36] S. File. Anxiolytic Action of a Neurokinin1 Receptor Antagonist in the Social Interaction Test , 1997, Pharmacology Biochemistry and Behavior.
[37] N. Singewald,et al. Release of excitatory and inhibitory amino acids from the locus coeruleus of conscious rats by cardiovascular stimuli and various forms of acute stress , 1995, Brain Research.
[38] N. Toschi,et al. Brain oxytocin inhibits the (re)activity of the hypothalamo–pituitary–adrenal axis in male rats: involvement of hypothalamic and limbic brain regions , 2000, Regulatory Peptides.
[39] R. Adamec. Amygdala kindling and anxiety in the rat. , 1990, Neuroreport.
[40] R G Hill,et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. , 1998, Science.
[41] M. Davidson,et al. Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment. , 2002, The Journal of clinical psychiatry.
[42] A. Siegel,et al. Evidence that substance P is utilized in medial amygdaloid facilitation of defensive rage behavior in the cat , 1993, Brain Research.
[43] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[44] A. Wheeldon,et al. Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalisation in guinea-pigs and mice , 2000, Neuropharmacology.
[45] S. Paradiso. The Emotional Brain: The Mysterious Underpinnings of Emotional Life , 1998 .
[46] N. Canteras,et al. Anxiogenic-like effect induced by substance P injected into the lateral septal nucleus. , 1999, Neuroreport.
[47] J. Calixto,et al. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. , 1996, European journal of pharmacology.
[48] K. Kovács,et al. Invited review c-Fos as a transcription factor: a stressful (re)view from a functional map , 1998, Neurochemistry International.
[49] M. Massi,et al. The psychopharmacology of tachykinin NK-3 receptors in laboratory animals , 2000, Peptides.
[50] K. Yoshioka,et al. Neurotransmitter functions of mammalian tachykinins. , 1993, Physiological reviews.
[51] E. Brodin,et al. Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions , 1994, Neuropeptides.
[52] A. Armario,et al. Recovery of the Hypothalamic-Pituitary-Adrenal Response to Stress , 2000, Neuroendocrinology.
[53] S. Boyce,et al. Intra-amygdala injection of the substance P (NK1 receptor) antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs , 2001, Neuropharmacology.
[54] T. Crow,et al. Distribution of neuropeptides in the limbic system of the rat: The amygdaloid complex , 1982, Neuroscience.
[55] U. Ungerstedt,et al. Potassium evoked in vivo release of substance P in rat caudate nucleus measured using a new technique of brain dialysis and an improved substance P-radioimmunoassay. , 1983, Acta physiologica Scandinavica. Supplementum.
[56] P. Zwanzger,et al. Substance P serum levels are increased in major depression: preliminary results , 2003, Biological Psychiatry.
[57] T. Hökfelt,et al. Neuroanatomical localisation of Substance P in the CNS and sensory neurons , 2000, Neuropeptides.
[58] R. Adamec,et al. The effect of kindling of different nuclei in the left and right amygdala on anxiety in the rat , 1994, Physiology & Behavior.
[59] K. McCarson,et al. Release of substance P into the superficial dorsal horn following nociceptive activation of the hindpaw of the rat , 1991, Brain Research.
[60] W. Wuttke,et al. Stress-induced changes in cholecystokinin and substance P concentrations in discrete regions of the rat hypothalamus. , 1987, Neuroendocrinology.
[61] R. Landgraf. Intracerebrally Released Vasopressin and Oxytocin: Measurement, Mechanisms and Behavioural Consequences , 1995, Journal of neuroendocrinology.
[62] D. Ganten,et al. Substance P Induces a Cardiovascular Defense Reaction in the Rat: Pharmacological Characterization , 1988, Circulation research.
[63] T. Hökfelt,et al. Distribution of substance P-like immunoreactivity in the central nervous system of the rat—I. Cell bodies and nerve terminals , 1978, Neuroscience.
[64] T. Moroji,et al. Effects of whole-body vibration stress on substance P- and neurotensin-like immunoreactivity in the rat brain. , 1990, Environmental research.
[65] George R. Breese,et al. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety , 1996, Brain Research.
[66] N. Singewald,et al. Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment , 2002, Neuropharmacology.